Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cortisol stimulation by recombinant interferon-alpha 2.

J Roosth, R B Pollard, S L Brown

    Journal of Neuroimmunology
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasis.

    Nature communications·2023
    Same author

    Low cost CO<sub>2</sub> sensing: A simple microcontroller approach with calibration and field use.

    HardwareX·2022
    Same author

    The effect of visual interventions on illness beliefs and medication adherence for chronic conditions: A scoping review of the literature and mapping to behaviour change techniques (BCTs).

    Research in social & administrative pharmacy : RSAP·2021
    Same author

    Corrigendum to "Ethnic and gender-specific incidence rates for hip fractures in South Africa: A multi-centre study" [Bone 133C (2020) 115253].

    Bone·2020
    Same author

    Ethnic and gender-specific incidence rates for hip fractures in South Africa: A multi-centre study.

    Bone·2020
    Same author

    Dosimetric evaluation and beam characterization of pair production enhanced radiotherapy (PPER) with the use of organometallics.

    Physics in medicine and biology·2019
    Same journal

    Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue.

    Journal of neuroimmunology·2026
    Same journal

    Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).

    Journal of neuroimmunology·2026
    Same journal

    Thymectomy promotes maintained complete stable remission in myasthenia gravis.

    Journal of neuroimmunology·2026
    Same journal

    Spinal cord microglia exhibit a dysfunctional response to myelin damage.

    Journal of neuroimmunology·2026
    Same journal

    Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

    Journal of neuroimmunology·2026
    Same journal

    Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

    Journal of neuroimmunology·2026
    See all related articles

    Recombinant interferon-alpha 2 therapy in cancer patients increased serum cortisol levels. This effect was dose-dependent, highlighting a significant side effect of this experimental cancer treatment.

    Area of Science:

    • Endocrinology
    • Oncology
    • Immunology

    Background:

    • Interferons are used in treating neurological and malignant diseases.
    • Understanding interferon actions and side effects is crucial for clinical applications.

    Purpose of the Study:

    • To investigate the effect of recombinant interferon-alpha 2 on serum cortisol concentrations in cancer patients.

    Main Methods:

    • Serum cortisol levels were measured using radioimmunoassay.
    • Patients received experimental therapy with recombinant interferon-alpha 2.
    • Cortisol concentrations were compared between interferon administration days and control days.

    Main Results:

    • Serum cortisol concentrations significantly increased 8 hours after interferon-alpha 2 administration.

    Related Experiment Videos

  • The elevation in cortisol levels was dose-dependent, increasing with higher weekly interferon doses.
  • Observed cortisol changes were significantly different from baseline levels.

    • Conclusions:

    • Recombinant interferon-alpha 2 administration leads to a notable increase in serum cortisol levels in cancer patients.
    • The observed cortisol elevation is a significant side effect of interferon-alpha 2 therapy.
    • Further research is warranted to understand the clinical implications of these endocrine changes.